Despised former drug CEO Martin Shkreli endorses Donald Trump

Before you go, we thought you'd like these...
Before you go close icon
Top 5 Facts about Martin Shkreli

Embattled former pharmaceutical CEO and hedge fund manager Martin Shkreli has endorsed Donald Trump for president.

"I haven't been called by the Trump camp," Shkreli tweeted Thursday. "I support him vs. Hillary. He should find a VP candidate who is seasoned in politics, an ugly game."

He also addressed people who are against Trump shortly after announcing his endorsement.

"All you people who don't like Trump are jealous, stupid and poor!" he said. "Don't make me laugh! And if you are employed by media you are worthless."

Shkreli, the pharmaceutical executive who drew widespread wrath for hiking up the price of HIV medications, was arrested on fraud charges in December.

In the same month, Shkreli bought a one-of-a-kind Wu-Tang Clan album titled "Once Upon a Time in Shaolin." While it's not known exactly how much Shkreli paid for the album, Bloomberg reported that he shelled out $2 million for the privilege of owning the only copy of the album that will ever be produced.

See Shkreli's outrageous faces during his congressional hearing:

15 PHOTOS
Martin Shkreli's outrageous faces during congressional hearing, Turing Pharmaceutical
See Gallery
Despised former drug CEO Martin Shkreli endorses Donald Trump
Martin Shkreli, former chief executive officer of Turing Pharmaceuticals LLC, reacts during a House Committee on Oversight and Government Reform hearing on prescription drug prices in Washington, D.C., U.S., on Thursday, Feb. 4, 2016. Shkreli, who is no longer with Turing and faces federal fraud charges unrelated to the drugmaker, declined to make any comments to the committee. 'On the advice of counsel, I invoke my Fifth Amendment,' Shkreli said. Photographer: Pete Marovich/Bloomberg via Getty Images
Entrepreneur and pharmaceutical executive Martin Shkreli listens during a hearing of the House Oversight and Government Reform Committee on Capitol Hill February 4, 2016 in Washington, DC. Martin Shkreli, the controversial former pharmaceuticals boss and hedge fund manager indicted on securities fraud charges, has been subpoenaed to appear at a hearing of a House of Representatives committee on oversight and government reform looking at the prescription drug market. / AFP / Brendan Smialowski (Photo credit should read BRENDAN SMIALOWSKI/AFP/Getty Images)
Entrepreneur and pharmaceutical executive Martin Shkreli waits for a car to pick him up after invoking his Fifth Amendment rights during a hearing of the House Oversight and Government Reform Committee on Capitol Hill February 4, 2016 in Washington, DC. Martin Shkreli, the controversial former pharmaceuticals boss and hedge fund manager indicted on securities fraud charges, has been subpoenaed to appear at a hearing of a House of Representatives committee on oversight and government reform looking at the prescription drug market. / AFP / Brendan Smialowski (Photo credit should read BRENDAN SMIALOWSKI/AFP/Getty Images)
Entrepreneur and pharmaceutical executive Martin Shkreli (L) leaves with his lawyer Benjamin Brafman after invoking his 5th Amendment rights during a hearing of the House Oversight and Government Reform Committee on Capitol Hill February 4, 2016 in Washington, DC. Martin Shkreli, the controversial former pharmaceuticals boss and hedge fund manager indicted on securities fraud charges, has been subpoenaed to appear at a hearing of a House of Representatives committee on oversight and government reform looking at the prescription drug market. / AFP / Brendan Smialowski (Photo credit should read BRENDAN SMIALOWSKI/AFP/Getty Images)
UNITED STATES - FEBRUARY 04: Martin Shkreli, center, former CEO of Turing Pharmaceuticals, leaves a House Oversight and Government Reform Committee in Rayburn Building on 'methods and reasoning behind recent drug price increases,' after invoking his Fifth Amendment right against self-incrimination, February 04, 2016. Turing had raised the price of Daraprim, a drug used by AIDS and cancer patients, from $13.50 to $750 a pill. (Photo By Tom Williams/CQ Roll Call)
WASHINGTON, DC - FEBRUARY 04: Martin Shkreli, former CEO of Turing Pharmaceuticals LLC., is sworn in during a House Oversight and Government Reform Committee hearing on Capitol Hill, February 4, 2016 in Washington, DC. Shkreli invoked his 5th Amendment right not to testify to the committee that is examining the prescription drug market. (Photo by Mark Wilson/Getty Images)
Martin Shkreli, former chief executive officer of Turing Pharmaceuticals LLC, is sworn in during a House Committee on Oversight and Government Reform hearing on prescription drug prices in Washington, D.C., U.S., on Thursday, Feb. 4, 2016. Shkreli, who is no longer with Turing and faces federal fraud charges unrelated to the drugmaker, declined to make any comments to the committee. 'On the advice of counsel, I invoke my Fifth Amendment,' Shkreli said. Photographer: Pete Marovich/Bloomberg via Getty Images
Martin Shkreli, former chief executive officer of Turing Pharmaceuticals LLC, reacts during a House Committee on Oversight and Government Reform hearing on prescription drug prices in Washington, D.C., U.S., on Thursday, Feb. 4, 2016. Shkreli, who is no longer with Turing and faces federal fraud charges unrelated to the drugmaker, declined to make any comments to the committee. 'On the advice of counsel, I invoke my Fifth Amendment,' Shkreli said. Photographer: Pete Marovich/Bloomberg via Getty Images
(L-R)Howard Schiller, interim CEO of Valeant Pharmaceuticals International, Inc., Nancy Retzlaff, chief commercial officer for Turing Pharmaceuticals LLC, and Martin Shkreli, former CEO of Turing Pharmaceuticals LLC, wait for a hearing of the House Oversight and Government Reform Committee on Capitol Hill February 4, 2016 in Washington, DC. Martin Shkreli, the controversial former pharmaceuticals boss and hedge fund manager indicted on securities fraud charges, has been subpoenaed to appear at a hearing of a House of Representatives committee on oversight and government reform looking at the prescription drug market. / AFP / Brendan Smialowski (Photo credit should read BRENDAN SMIALOWSKI/AFP/Getty Images)
WASHINGTON, DC - FEBRUARY 04: Martin Shkreli, former CEO of Turing Pharmaceuticals LLC., smiles while flanked by Nancy Retzlaff, chief commercial officer for Turing Pharmaceuticals LLC., during a House Oversight and Government Reform Committee hearing on Capitol Hill, February 4, 2016 in Washington, DC. Shkreli invoked his 5th Amendment right not to testify to the committee that is examining the prescription drug market. (Photo by Mark Wilson/Getty Images)
Pharmaceutical chief Martin Shkreli listens on Capitol Hill in Washington, Thursday, Feb. 4, 2016, during the House Committee on Oversight and Reform Committee hearing on his former company's decision to raise the price of a lifesaving medicine. Shkreli refused to testify before U.S. lawmakers who excoriated him over severe hikes for a drug sold by a company that he acquired. (AP Photo/Susan Walsh)
Martin Shkreli, former chief executive officer of Turing Pharmaceuticals LLC, smiles during a House Committee on Oversight and Government Reform hearing on prescription drug prices in Washington, D.C., U.S., on Thursday, Feb. 4, 2016. Shkreli, who is no longer with Turing and faces federal fraud charges unrelated to the drugmaker, declined to make any comments to the committee. 'On the advice of counsel, I invoke my Fifth Amendment,' Shkreli said. Photographer: Pete Marovich/Bloomberg via Getty Images
Martin Shkreli, former chief executive officer of Turing Pharmaceuticals LLC, smiles during a House Committee on Oversight and Government Reform hearing on prescription drug prices in Washington, D.C., U.S., on Thursday, Feb. 4, 2016. Shkreli, who is no longer with Turing and faces federal fraud charges unrelated to the drugmaker, declined to make any comments to the committee. 'On the advice of counsel, I invoke my Fifth Amendment,' Shkreli said. Photographer: Pete Marovich/Bloomberg via Getty Images
Martin Shkreli, former chief executive officer of Turing Pharmaceuticals LLC, left, listens as his attorney Benjamin Brafman speaks the media after a House Committee on Oversight and Government Reform hearing on prescription drug prices in Washington, D.C., U.S., on Thursday, Feb. 4, 2016. Shkreli, who is no longer with Turing and faces federal fraud charges unrelated to the drugmaker, declined to make any comments to the committee. 'On the advice of counsel, I invoke my Fifth Amendment,' Shkreli said. Photographer: Pete Marovich/Bloomberg via Getty Images
of
SEE ALL
BACK TO SLIDE
SHOW CAPTION +
HIDE CAPTION

One month later, the disgraced exec said he might destroy the album or put it in some remote place so people have to go on some sort of "spiritual quest" to listen to it.

See Shkreli's tweet below.

Read original story Despised Former Drug CEO Martin Shkreli Endorses Donald Trump At TheWrap

Read Full Story

Sign up for Breaking News by AOL to get the latest breaking news alerts and updates delivered straight to your inbox.

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners